Home » Topics » Regulatory » Patents

Patents
RSS

New antidepressant compounds in development at HMR

Dec. 12, 1996

Tyrosine kinase inhibitors described by Pharmacia & Upjohn

Dec. 12, 1996

New hypolipidemic agents claimed by Janssen

Dec. 12, 1996

Positive GABAA receptor complex modulators claimed

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Allelix reports thrombospondin-derived antihemorrhagic peptide

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.